Therapy Evaluation With Kaletra: 5 Year Long-term Effect in Patients With Non-B-subtypes Infections.

Trial Profile

Therapy Evaluation With Kaletra: 5 Year Long-term Effect in Patients With Non-B-subtypes Infections.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Jan 2013

At a glance

  • Drugs Lopinavir/ritonavir (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 18 Nov 2010 Additional lead trial investigator (Stefan Simianer) identified as reported by ClinicalTrials.gov.
    • 10 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top